Chronic Myeloid Leukaemia: Clinical Trials

1 trial for Chronic Myeloid Leukaemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Chronic Myeloid Leukaemia: new trials by email Literature Review of Chronic Myeloid Leukaemia trials Research Report on Chronic Myeloid Leukaemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GlivecĀ® (Imatinib Mesylate, STI571) in Monotherapy Versus GlivecĀ®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
Glivec, Interferon - Chronic Myeloid Leukaemia
Phase 4CompletedPETHEMA Foundation3602003-07-012008-11-27

Narrower conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Myeloproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Imatinib Mesylate (1)  ·  Interferons (1)

Sponsors

PETHEMA Foundation (1)

Countries

Spain (1)

Top investigators

Cervantes Francisco, Dr (1)

Results publications

PMID 20220063